OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 12, 2013, Pages 1458-1470

  Schordan, Sandra ^a   Grisk, Olaf ^a   Schordan, Eric ^a   Miehe, Bärbel ^a   Rumpel, Elisabeth ^a   Endlich, Karlhans ^a   Giebel, Jürgen ^a   Endlich, Nicole ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

FSGS; Nephrectomy; Osteopontin; Podocyte

Indexed keywords

ALBUMIN; DEOXYCORTICOSTERONE ACETATE; F ACTIN; OSTEOPONTIN; PODOCIN; PROTEIN; SYNAPTOPODIN;

ALBUMINURIA; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BOWMAN CAPSULE; CELL DAMAGE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBROSING ALVEOLITIS; FOCAL GLOMERULOSCLEROSIS; GLOMERULAR FILTRATION BARRIER; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; KIDNEY CORTEX; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY MASS; KIDNEY TUBULE BASEMENT MEMBRANE; MALE; MORPHOLOGICAL TRAIT; MOUSE; NEPHROBLASTOMA; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; UNINEPHRECTOMY;

EID: 84879183972     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00615.2012     Document Type: Article

References (51)

1. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, Frye B, Elger M, Kriz W, Floege J, Moeller MJ. Recruitment of podocytes from glomer-ular parietal epithelial cells. J Am Soc Nephrol 20: 333-343, 2009.
2. Asanuma K, Mundel P. The role of podocytes in glomerular pathobiol-ogy. Clin Exp Nephrol 7: 255-259, 2003.
3. Barisoni L. Podocyte biology in segmental sclerosis and progressive glomerular injury. Adv Chronic Kidney Dis 19: 76-83, 2012.
4. Endlich N, Kress KR, Reiser J, Uttenweiler D, Kriz W, Mundel P, Endlich K. Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 12: 413-422, 2001.
5. Endlich N, Sunohara M, Nietfeld W, Wolski EW, Schiwek D, Kran-zlin B, Gretz N, Kriz W, Eickhoff H, Endlich K. Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J 16: 1850-1852, 2002.
6. Farris AB, Colvin RB. Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens 21: 289-300, 2012.
7. Florentin A, Arama E. Caspase levels and execution efficiencies determine the apoptotic potential of the cell. J Cell Biol 196: 513-527, 2012.
8. Fogo AB. Current concepts in glomerulosclerosis. Am J Kidney Dis 34: LIV-LVI, 1999.
9. Friedrich C, Endlich N, Kriz W, Endlich K. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal Physiol 291: F856-F865, 2006.
10. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152: 353-358, 1998.
11. Glauert AM. Practical Methods in Electron Microscopy. Philadelphia, PA: Elsevier Science, 1975, ISBN 0-7204-4260-5.
12. Hampel DJ, Sansome C, Romanov VI, Kowalski AJ, Denhardt DT, Goligorsky MS. Osteopontin traffic in hypoxic renal epithelial cells. Nephron Exp Nephrol 94: e66-e76, 2003.
13. Harris J, Hanrahan O, De Haro SA. Measuring autophagy in macrophages. Curr Protoc Immunol 14: Unit 14.14, 2009.
14. Hartner A, Porst M, Gauer S, Prols F, Veelken R, Hilgers KF. Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats. Am J Kidney Dis 38: 153-164, 2001.
15. Hausmann J, Jelinek J, Deyl Z. Changes in glomerular basement membrane collagen caused by DOCA-NaCl treatment in rats. Nephron 39: 250-254, 1985.
16. Irita J, Okura T, Kurata M, Miyoshi K, Fukuoka T, Higaki J. Osteopontin in rat renal fibroblasts: functional properties and transcriptional regulation by aldosterone. Hypertension 51: 507-513, 2008.
17. Jensen PK, Steven K. Influence of intratubular pressure on proximal tubular compliance and capillary diameter in the rat kidney. Pflügers Arch 382: 179-187, 1979.
18. Ji X, Naito Y, Weng H, Endo K, Ma X, Iwai N. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate (DOCA)-salt hypertension. Am J Physiol Renal Physiol 303: F1207-F1215, 2012.
19. Kang JA, Zhou Y, Weis TL, Liu H, Ulaszek J, Satgurunathan N, Zhou L, van Besien K, Crispino J, Verma A, Low PS, Wickrema A. Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. J Biol Chem 283: 6997-7006, 2008.
20. Kretzler M, Koeppen-Hagemann I, Kriz W. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrec-tomised-desoxycorticosterone hypertensive rat. Virchows Arch 425: 181-193, 1994.
21. Kriz W, Hosser H, Hahnel B, Gretz N, Provoost AP. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant 13: 2781-2798, 1998.
22. Lewko B, Endlich N, Kriz W, Stepinski J, Endlich K. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress. Kidney Int 66: 1001-1008, 2004.
23. Li JJ, Kwak SJ, Jung DS, Kim JJ, Yoo TH, Ryu DR, Han SH, Choi HY, Lee JE, Moon SJ, Kim DK, Han DS, Kang SW. Podocyte biology in diabetic nephropathy. Kidney Int Suppl S36-S42, 2007.
24. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74: 214-224, 1994.
25. Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kun-zendorf U, Krautwald S. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81: 751-761, 2012.
26. Lorenzen J, Shah R, Biser A, Staicu SA, Niranjan T, Garcia AM, Gruenwald A, Thomas DB, Shatat IF, Supe K, Woroniecki RP, Susztak K. The role of osteopontin in the development of albuminuria. J Am Soc Nephrol 19: 884-890, 2008.
27. Mandache E, Penescu M. Nanostructural features of diabetic podocy-topathy. Rom J Morphol Embryol 53: 23-27, 2012.
28. Miner JH. The glomerular basement membrane. Exp Cell Res 318: 973-978, 2012.
29. + channel: potential implications for the control of glomerular filtration. J Am Soc Nephrol 15: 2981-2987, 2004.
30. Nagao T, Okura T, Irita J, Jotoku M, Enomoto D, Desilva VR, Miyoshi K, Kurata M, Matsui Y, Uede T, Higaki J. Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy. Nephron Extra 2: 87-103, 2012.
31. Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol 170: 36-47, 2011.
32. Noel LH. Morphological features of primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant 14, Suppl 3: 53-57, 1999.
33. Noiri E, Dickman K, Miller F, Romanov G, Romanov VI, Shaw R, Chambers AF, Rittling SR, Denhardt DT, Goligorsky MS. Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int 56: 74-82, 1999.
34. Park JK, Theuer S, Kirsch T, Lindschau C, Klinge U, Heuser A, Plehm R, Todiras M, Carmeliet P, Haller H, Luft FC, Muller DN, Fiebeler A. Growth arrest specific protein 6 participates in DOCA-induced target-organ damage. Hypertension 54: 359-364, 2009.
35. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003.
36. Persy VP, Verhulst A, Ysebaert DK, De Greef KE, De Broe ME. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63: 543-553, 2003.
37. Petermann AT, Hiromura K, Blonski M, Pippin J, Monkawa T, Durvasula R, Couser WG, Shankland SJ. Mechanical stress reduces podocyte proliferation in vitro. Kidney Int 61: 40-50, 2002.
38. Picard N, Baum O, Vogetseder A, Kaissling B, Le Hir M. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol 130: 141-155, 2008.
39. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13: 1101-1111, 1998.
40. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 24: 550-560, 2004.
41. Schiwek D, Endlich N, Holzman L, Holthofer H, Kriz W, Endlich K. Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. Kidney Int 66: 91-101, 2004.
42. Schordan S, Schordan E, Endlich K, Endlich N. aV-Integrins mediate the mechanoprotective action of osteopontin in podocytes. Am J Physiol Renal Physiol 300: F119-F132, 2011.
43. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 149: 293-305, 1996.
44. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006.
45. Shui HA, Ka SM, Yang SM, Lin YF, Lo YF, Chen A. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis. Transl Res 150: 216-222, 2007.
46. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, van Kuppevelt TH, Endlich K, Wetzels JF, Grone HJ, Floege J, Moeller MJ. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 22: 1262-1274, 2011.
47. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794, 2004.
48. Taal MW and Brenner BM. Adaptation to nephron loss in the kidney. In: Brenner & Rector's The Kidney, edited by Brenner BM. Philadelphia: Elsevier Saunders, 2008.
49. Tonna SJ, Needham A, Polu K, Uscinski A, Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, Savige J, Harmon J, Zhang K, Curhan GC, Pollak MR. NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol 9: 13, 2008.
50. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005.
51. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60: 1645-1657, 2001.